Aptevo Therapeutics Inc. · GETTEX:AP82

Aptevo Therapeutics Inc. shareholders

As of Sep 30, 2026, 10 institutions reported holding Aptevo Therapeutics Inc., 9.8% of its shares. Largest: Sabby Management, LLC, Hudson Bay Capital Management LP and Citadel. New holders, exits, insiders and big stakes, each with its filing.

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Sabby Management, LLC233K6.7%US$423KSep 30, 2026
Hudson Bay Capital Management LP40,7001.2%US$74,074Sep 30, 2026
Citadel25,1710.73%US$45,811Sep 30, 2026
Gsa Capital Partners LLP21,5390.62%US$39,000Sep 30, 2026
Vanguard16,8550.49%US$30,676Sep 30, 2026
Tower Research Capital LLC (TRC)1,9110.06%US$3,478Sep 30, 2026
Osaic Holdings, Inc.3600.01%US$664Sep 30, 2026
SBI Securities Co., Ltd.105<0.01%US$191Sep 30, 2026
Caitong International Asset Management Co., Ltd3<0.01%US$5Sep 30, 2026
Danske Bank A/S1<0.01%US$2Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Extended Market Index Fund12,7130.37%US$56,446Jun 30, 2026
Fidelity Extended Market Index Fund8,9010.26%US$43,704May 31, 2026
Fidelity Series Total Market Index Fund1,5480.04%US$7,601May 31, 2026

Big stakes

StakeStakeSharesDateFiling
NIOWAVE, INC.12.20%152KMay 25, 2026Schedule 13G

Aptevo Therapeutics Inc. insider trades